Molina Healthcare director proposes $147K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
144
Rhea-AI Filing Summary
Molina Healthcare, Inc. (MOH) director Steven Orlando is identified in a notice as proposing to sell 702 common shares for an aggregate market value of $146,700, with an approximate sale date of November 16, 2026.
Key Figures
Common shares proposed for sale: 702 shares
Aggregate market value: $146,700
Common shares outstanding: 52,200,000 shares
+3 more
6 metrics
Common shares proposed for sale
702 shares
Approximate sale date November 16, 2026
Aggregate market value
$146,700
For the 702 common shares proposed for sale
Common shares outstanding
52,200,000 shares
Number listed in the securities information
Director stock grant
237 shares
Acquired July 6, 2026
Director stock grant
285 shares
Acquired October 6, 2025
Director stock grant
180 shares
Acquired July 3, 2025
Key Terms
Rule 16b-3
1 terms
Rule 16b-3 regulatory
"Grants for Director rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.